Initial therapy with combination of five antibiotics in febrile patients with leukaemia and neutropenia.
D000284:Administration, Oral; D000380:Agranulocytosis / Q000150:complications*; D000741:Anemia, Aplastic / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002228:Carbenicillin / Q000008:administration & dosage; D002512:Cephalothin / Q000008:administration & dosage; D002981:Clindamycin / Q000008:administration & dosage; D004338:Drug Combinations; D004342:Drug Hypersensitivity / Q000150:complications; D004927:Escherichia coli Infections / Q000188:drug therapy; D005334:Fever; D005839:Gentamicins / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D007612:Kanamycin / Q000008:administration & dosage; D007710:Klebsiella Infections / Q000188:drug therapy; D007938:Leukemia / Q000150:complications*; D007958:Leukocyte Count; D008223:Lymphoma / Q000150:complications*; D008712:Methicillin / Q000008:administration & dosage; D010400:Penicillin G / Q000008:administration & dosage; D010403:Penicillin Resistance; D011113:Polymyxins / Q000008:administration & dosage; D011339:Probenecid / Q000008:administration & dosage; D011552:Pseudomonas Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005839:Gentamicins; D011113:Polymyxins; D002981:Clindamycin; D007612:Kanamycin; D002228:Carbenicillin; D011339:Probenecid; D010400:Penicillin G; D008712:Methicillin; D002512:Cephalothin